📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! Tell us what works, what doesn't, and how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community. Please send your feedback to gateway@ukri.org by 11 August 2025.

Response to SARS-CoV-2 vaccination in multiple sclerosis patients on disease modifying therapies (2022)

First Author: Allman M

Attributed to: MRC Centre for Neuropsychiatric Genetics and Genomics funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1007/s00415-022-11053-7

PubMed Identifier: 35286479

Publication URI: http://europepmc.org/abstract/MED/35286479

Type: Journal Article/Review

Parent Publication: Journal of Neurology

Issue: 4

ISSN: 0340-5354